NanoViricides
NNVC
32 hedge funds and large institutions have $2.01M invested in NanoViricides in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
113% more call options, than puts
Call options by funds: $49K | Put options by funds: $23K
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
0.02% less ownership
Funds ownership: 11.38% → 11.35% (-0.02%)
6% less funds holding
Funds holding: 34 → 32 (-2)
13% less capital invested
Capital invested by funds: $2.31M → $2.01M (-$299K)
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| 1 |
IWC
Integrated Wealth Concepts
Waltham,
Massachusetts
|
+$30.6K |
| 2 |
Renaissance Technologies
New York
|
+$23.8K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$22.1K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$5.25K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$4.99K |
Top Sellers
NNVC Hedge Fund Activity: Q3 2024 in Review
32 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2024, worth a combined $2.01M — down 13% from $2.31M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of NNVC and 3 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 6 added.
The largest buyer was Integrated Wealth Concepts, adding an estimated $30.6K. The largest seller was Bridgeway Capital Management, cutting an estimated $27.8K.
- 32 institutional investors held NanoViricides (NNVC) as of Q3 2024, down from 34 in Q2 2024.
- Funds reported $2.01M of NanoViricides stock for Q3 2024, down 13% quarter-over-quarter.
- 3 funds opened new NanoViricides positions in Q3 2024 and 5 closed out, a net change of -2 holders.
- The largest NanoViricides buyer in Q3 2024 was Integrated Wealth Concepts, an estimated $30.6K added.
- The largest NanoViricides seller in Q3 2024 was Bridgeway Capital Management, an estimated $27.8K sold.
Based on aggregated 13F filings for Q3 2024.